Human papillomavirus (HPV), when left untreated, can lead to onset cervical cancer. Currently 80% of deaths from cervical cancer occur in low- or middle-income countries (LMICs), which do not have the resources for proper HPV testing.¹ My research plan is to develop cheaper and novel methods to isolate and test for high-risk HPV 16/18 DNA. This will include working off of previous work from my mentors, who created more affordable methods, using AI technology, assays, and dimer formation, to test for HPV. Currently, a large portion of the cost to be cut lay in the DNA isolation and assay portion of these tests. To take on this challenge, I plan to work with less traditional DNA isolation methods in order to find a cost-friendly method. If successful, this research would allow for more early intervention, ultimately preventing the prevalence of cervical cancer in  LMICs.